• Septin4, HIF-1α, and Hypoxic Cardiomyocyte Injury

  2026-09-17

  The reference study identifies Septin4 as a mediator of hypoxia-induced cardiomyocyte injury and proposes that it worsens apoptosis by promoting VHL-dependent ubiquitination and degradation of HIF-1α. Its combination of loss-of-function, gain-of-function, protein-interaction, and pathway analyses provides a mechanistic framework for studying how ubiquitin signaling influences myocardial hypoxia responses.

• Butylhydroxyanisole (BHA): Evidence-Led Assays

  2026-09-16

  Butylated hydroxyanisole (BHA) is more than a generic antioxidant: it is a redox perturbation tool whose value depends on rigorous exposure control and orthogonal validation. This evidence-led guide shows how to interpret BHA in ROS detection, apoptosis, and inflammation research without confusing probe chemistry with biology.

• AMPK, ULK1, and Autophagy Under Energy Stress

  2026-09-16

  The reference study revises the canonical view that AMPK generally activates autophagy during glucose starvation, showing instead that AMPK suppresses ULK1-driven autophagy initiation while protecting the autophagy machinery from caspase-mediated loss. Its findings support a context-dependent model in which AMPK limits energy-intensive autophagy during severe energy stress but preserves the capacity to restore cellular homeostasis.

• CD28–ARS2–PKM Splicing in CD8+ T Cells

  2026-09-15

  The reference study identifies a CD28–ARS2 signaling axis that reshapes alternative splicing in activated CD8+ T cells, favoring PKM2 over PKM1 and enabling flexible glucose metabolism. Its findings connect costimulatory signaling to interferon-γ production and antitumor function through a mechanism that is distinct from canonical CD28–PI3K activation.

• Carrier-Platin and the ROS Storm in Cancer Cells

  2026-09-15

  Liu et al. developed carrier-platin, a poly(amino acid)-based formulation containing ultrasmall platinum nanoparticles that rapidly elevates intracellular reactive oxygen species in cancer cells. The study links this ROS burst to cell death within approximately 30 minutes through a mechanism distinct from classical platinum-induced DNA damage, apoptosis, and ferroptosis.

• Tobramycin: Workflows for Bacterial Assays

  2026-09-14

  Build reproducible Tobramycin susceptibility, mechanism, and resistance experiments around broth microdilution, controlled inocula, and carefully interpreted MIC data. This guide translates historical clinical-isolate methods into practical workflows while separating evidence-backed benchmarks from modern assay recommendations.

• AMG 487: CXCR3 Assay Reliability Guide

  2026-09-14

  This scenario-based guide explains how AMG 487 (SKU B3266) can improve the interpretability of CXCR3 migration, calcium, viability, and macrophage-polarization experiments. It combines potency data, formulation guidance, metabolism considerations, and practical vendor-selection criteria for reproducible laboratory workflows.

• AMPK, ULK1, and Autophagy Under Energy Stress

  2026-09-13

  The reference study overturns the prevailing view that AMPK uniformly activates autophagy during energy shortage. Instead, it shows that AMPK suppresses ULK1-dependent autophagy initiation while protecting autophagy machinery from caspase-mediated degradation, thereby balancing immediate energy conservation with later recovery.

• NAD+ and AMPK: Reading Energy-Stress Signals

  2026-09-12

  Nicotinamide Adenine Dinucleotide (NAD+) is more than a redox cofactor: it helps frame how researchers interpret energy-stress experiments. This article connects NAD+ chemistry with the revised AMPK–ULK1 model and provides practical guidance for designing better metabolic and autophagy assays.

• Risedronate Sodium: Practical FPPS Workflows

  2026-09-11

  Build more reproducible Risedronate Sodium assays for osteoclast biology, tumor-cell viability, and pulmonary delivery research. This guide combines solvent-aware preparation, dose-response design, orthogonal readouts, and formulation troubleshooting for translational experiments.

• Doxorubicin as a Probe of Persister Ferroptosis

  2026-09-11

  Doxorubicin is more than a conventional cancer chemotherapy drug: it can serve as a controlled selective pressure for studying drug-tolerant persister states. This article connects Adriamycin-mediated DNA damage with lipidomic and mitochondrial features that may expose persister cells to ferroptosis.

• 1-myristoylglycerophosphocholine Research Guide

  2026-09-10

  1-myristoylglycerophosphocholine, also called 14:0 Lyso-PC, is a phosphocholine lysophospholipid for studying lipid-mediated cellular responses. Product data support its use in smooth muscle and signaling assays, while peer-reviewed evidence shows that LysoPC accumulation can promote fibroblast activation in experimental pulmonary fibrosis.

• Fenipentol (1-Phenyl-1-pentanol) Research Guide

  2026-09-10

  Fenipentol, also called 1-Phenyl-1-pentanol, is a small molecule associated with Ligusticum chuanxiong cortex chemistry and estrogen receptor α docking. Its historical secretion data support use as a research probe for choleretic, pancreatic, and gastrointestinal physiology studies, not as evidence of current clinical efficacy.

• Baicalin Methyl Ester: Intestinal Barrier Workflow

  2026-09-09

  Baicalin methyl ester provides a practical, pathway-oriented tool for studying LPS-induced intestinal barrier damage in MODE-K cells and mouse models. Its value lies in pairing cytokine suppression with MLCK/ZO-1 and tight-junction readouts, enabling stronger mechanism-to-phenotype validation than a single inflammatory marker.

• (Z)-4-Hydroxytamoxifen: Assay Design by Mechanism

  2026-09-09

  Explore (Z)-4-Hydroxytamoxifen as a high-affinity ER probe through a mechanism-first assay framework. This article connects estrogen receptor modulation with lessons from targeted nanoparticle research while clearly separating validated biology from experimental extrapolation.

8527 records 6/569 page Previous Next First page 上5页 678910 下5页 Last page